MicroRNA-365 Targets Multiple Oncogenes to Inhibit Proliferation, Invasion, and Self-Renewal of Aggressive Endometrial Cancer Cells [Retraction]

Abstract

Wang C, Su K, Zhang Y, et al. Cancer Manag Res. 2018;10:5171–5185. At the authors request, the Editor and Publisher of Cancer Management and Research wish to retract the published article. The authors have advised that the human EC SPAC-1-S and -1-L cell lines used in the study were contaminated with other cell lines and the results described are invalid. The Editor agrees with the decision to retract the article. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper

Keywords

• microrna-365
• endometrial cancer
• paclitaxel
• ezh2
• fos